Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent.
about
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.Immunotherapeutic and antitumour potential of thalidomide analogues.Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes.Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.Thalidomide in relapsed or refractory multiple myeloma: how much and for how long?Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD.An investigation of the effect of thalidomide on anti-gal antibody production in baboons.Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
P2860
Q34034447-73122FC9-E552-485A-8B0B-EA289C4278D8Q34451909-A1F4D187-52C9-4C1B-AF09-E25812FD0CF1Q35104368-C7FF08D2-95E7-4056-99C1-1910B11AD787Q36696902-EF359177-5284-48C6-8C3A-990CC46449B1Q43861740-F885CC06-7C99-4CBC-B162-DFE9D382B6BFQ43973073-70E154E2-565A-4428-BBBD-B706FF07881EQ44086019-BEDBF656-97D6-4612-AA6E-F95EE9C1DD48Q44150673-2D9CFA81-DD53-4507-9FBE-EBB52CC06D6DQ44509206-61F216A6-7888-4D28-97F2-5E8E5C4D56BDQ44511403-186B0452-987E-482D-87C7-DE15B8110C07Q44570347-EF1B4D25-9966-43F9-B895-E9B528046AD2Q48682753-9CC35FF4-F06B-47A9-9551-8F5B1DC10A9A
P2860
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Successful treatment of multip ...... thalidomide as a single agent.
@en
Successful treatment of multip ...... thalidomide as a single agent.
@nl
type
label
Successful treatment of multip ...... thalidomide as a single agent.
@en
Successful treatment of multip ...... thalidomide as a single agent.
@nl
prefLabel
Successful treatment of multip ...... thalidomide as a single agent.
@en
Successful treatment of multip ...... thalidomide as a single agent.
@nl
P2860
P356
P1476
Successful treatment of multip ...... thalidomide as a single agent.
@en
P2093
Anagnostopoulos N
P2860
P2888
P304
P356
10.1038/SJ.BMT.1702444
P407
P577
2000-06-01T00:00:00Z
P6179
1010458562